• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗流感病毒的物质。应用的可能性与前景]

[The substances active against influenza virus. Possibilities and prospects of application].

作者信息

Kwiatek Magdalena, Kocik Janusz, Bartoszcze Michał

机构信息

Wojskowy Instytut Higieny i Epidemiologii, Warszawa.

出版信息

Przegl Epidemiol. 2009;63(4):487-94.

PMID:20120945
Abstract

Influenza, especially pandemic influenza, poses great threat to health and humans life of. Due to the antigenic drift and shift of the influenza virus, there is a constant requirement to accurately adjust contents of the vaccine to current subtype of the virus. As there is always a long period of time between the moment of detection of a new kind of influenza virus till a new vaccine is produced, the only protection for the people are antiviral drugs. Some examples of antiviral compounds that can be used in treatment in near future have been presented. A review of the researches on the substances that are active against influenza viruses has been carried out and their mechanism of action was described. We have taken into account the chemical compounds that seem to be active in the process of virus adsorption; hemagglutinin and neuraminidase inhibitors; M2 ion channel blockers; polymerase, endonuclease, transcriptase, proteine kinase and signaling cascade inhibitors. The potential of oligonucleotide antiviral therapeutics and the substances that are extracted from different plants were presented. The future direction of research were shown.

摘要

流感,尤其是大流行性流感,对健康和人类生命构成巨大威胁。由于流感病毒的抗原漂移和转变,始终需要根据当前病毒亚型准确调整疫苗成分。从检测到新型流感病毒到生产新疫苗之间总会有很长一段时间,对人们来说唯一的保护就是抗病毒药物。文中列举了一些在不久的将来可用于治疗的抗病毒化合物实例。对针对流感病毒有活性的物质的研究进行了综述,并描述了它们的作用机制。我们考虑了在病毒吸附过程中似乎有活性的化合物;血凝素和神经氨酸酶抑制剂;M2离子通道阻滞剂;聚合酶、核酸内切酶、转录酶、蛋白激酶和信号级联抑制剂。还介绍了寡核苷酸抗病毒疗法的潜力以及从不同植物中提取的物质。展示了未来的研究方向。

相似文献

1
[The substances active against influenza virus. Possibilities and prospects of application].[抗流感病毒的物质。应用的可能性与前景]
Przegl Epidemiol. 2009;63(4):487-94.
2
Anti-influenza drugs: the development of sialidase inhibitors.抗流感药物:唾液酸酶抑制剂的研发
Handb Exp Pharmacol. 2009(189):111-54. doi: 10.1007/978-3-540-79086-0_5.
3
Antivirals and influenza: frequency of resistance.抗病毒药物与流感:耐药频率
Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S110-2. doi: 10.1097/INF.0b013e318168b739.
4
Antiviral management of seasonal and pandemic influenza.季节性流感和大流行性流感的抗病毒治疗
J Infect Dis. 2006 Nov 1;194 Suppl 2:S119-26. doi: 10.1086/507552.
5
Antivirals for influenza: historical perspectives and lessons learned.流感抗病毒药物:历史回顾与经验教训
Antiviral Res. 2006 Sep;71(2-3):372-8. doi: 10.1016/j.antiviral.2006.05.016. Epub 2006 Jun 9.
6
Pandemic flu vaccine: are we doing enough?大流行性流感疫苗:我们做得够吗?
Clin Pharmacol Ther. 2007 Dec;82(6):633-5. doi: 10.1038/sj.clpt.6100417.
7
Research paths to successful prevention and treatment of swine-derived H1N1 influenza virus infection.
Drug News Perspect. 2010 Jan-Feb;23(1):65-70. doi: 10.1358/dnp.2010.23.1.1416985.
8
Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.大流行、甲型禽流感(H5N1)以及药剂师的一项策略。
Pharmacotherapy. 2006 Mar;26(3):312-22. doi: 10.1592/phco.26.3.312.
9
Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.流感病毒准种中神经氨酸酶抑制剂耐药性的快速定量分析
Antivir Ther. 2008;13(6):809-20.
10
Implications of antiviral resistance of influenza viruses.流感病毒抗病毒耐药性的影响
Clin Infect Dis. 2009 Feb 15;48(4):397-9. doi: 10.1086/596312.